GlassScriptPhysician profile
Renata Scott-Ram
NPI 1225290455
$1,017.58
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.51 · 2022: $423 · 2023: $371 · 2024: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.80 | 2022-2023 | Liletta, Lo Loestrin Fe |
| Exeltis, USA INC. | $119.52 | 2022-2024 | Slynd |
| Evofem Biosciences, INC. | $103.45 | 2023-2024 | Phexxi |
| Daiichi Sankyo INC. | $88.24 | 2022-2024 | Injectafer |
| Organon LLC | $88.14 | 2022-2024 | Nexplanon |
| Astellas Pharma US INC | $79.69 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $75.11 | 2022-2024 | |
| Myovant Sciences INC. | $45.91 | 2022 | |
| Merck Sharp & Dohme LLC | $41.72 | 2019-2024 | Gardasil 9, Gardasil |
| Alexion Pharmaceuticals, INC. | $41.03 | 2022 | |
| Scynexis, INC. | $36.22 | 2022 | |
| Sumitomo Pharma America, INC. | $32.02 | 2023 | Myfembree |
| Ethicon US, LLC | $21.55 | 2022 | |
| Hologic Sales and Service, LLC | $20.76 | 2023 | Aptima |
| Agile Therapeutics, INC. | $20.72 | 2024 | Twirla |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Scott-Ram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.